Bergerheim US - Search Results

1

Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.

Pan Y, Kytölä S, Farnebo F, Wang N, Lui WO, Nupponen N, Isola J, Visakorpi T, Bergerheim US, Larsson C. Pan Y, et al. Among authors: bergerheim us. Cytogenet Cell Genet. 1999;87(3-4):225-32. doi: 10.1159/000015432. Cytogenet Cell Genet. 1999. PMID: 10702678

2

5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines.

Pan Y, Lui WO, Nupponen N, Larsson C, Isola J, Visakorpi T, Bergerheim US, Kytölä S. Pan Y, et al. Among authors: bergerheim us. Genes Chromosomes Cancer. 2001 Feb;30(2):187-95. Genes Chromosomes Cancer. 2001. PMID: 11135436

3

Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis.

Fadl-Elmula I, Kytölä S, Pan Y, Lui WO, Derienzo G, Forsberg L, Mandahl N, Gorunova L, Bergerheim US, Heim S, Larsson C. Fadl-Elmula I, et al. Among authors: bergerheim us. Int J Cancer. 2001 Jun 15;92(6):824-31. doi: 10.1002/ijc.1267. Int J Cancer. 2001. PMID: 11351302

4

Chromosomal numerical aberrations detected by fluorescence in situ hybridization on bladder washings from patients with bladder cancer.

Marano A, Pan Y, Li C, Pagliarulo A, Elmberger G, Tribukait B, Ekman P, Bergerheim U. Marano A, et al. Eur Urol. 2000 Mar;37(3):358-65. doi: 10.1159/000052370. Eur Urol. 2000. PMID: 10720866

5

Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.

Mahdy E, Pan Y, Wang N, Malmström PU, Ekman P, Bergerheim U. Mahdy E, et al. Anticancer Res. 2001 Sep-Oct;21(5):3167-73. Anticancer Res. 2001. PMID: 11848469

6

Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer.

Matsuyama H, Bergerheim US, Nilsson I, Pan Y, Skoog L, Tribukait B, Ekman P. Matsuyama H, et al. Among authors: bergerheim us. Cancer Genet Cytogenet. 1994 Oct 15;77(2):118-24. doi: 10.1016/0165-4608(94)90226-7. Cancer Genet Cytogenet. 1994. PMID: 7954321

7

Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization.

Matsuyama H, Pan Y, Skoog L, Tribukait B, Naito K, Ekman P, Lichter P, Bergerheim US. Matsuyama H, et al. Among authors: bergerheim us. Oncogene. 1994 Oct;9(10):3071-6. Oncogene. 1994. PMID: 8084616

8

Identification of two distinct deleted regions on chromosome 13 in prostate cancer.

Li C, Larsson C, Futreal A, Lancaster J, Phelan C, Aspenblad U, Sundelin B, Liu Y, Ekman P, Auer G, Bergerheim US. Li C, et al. Among authors: bergerheim us. Oncogene. 1998 Jan 29;16(4):481-7. doi: 10.1038/sj.onc.1201554. Oncogene. 1998. PMID: 9484837

9

Chromosome 16q24 deletion and decreased E-cadherin expression: possible association with metastatic potential in prostate cancer.

Pan Y, Matsuyama H, Wang N, Yoshihiro S, Häggarth L, Li C, Tribukait B, Ekman P, Bergerheim US. Pan Y, et al. Among authors: bergerheim us. Prostate. 1998 Jun 15;36(1):31-8. doi: 10.1002/(sici)1097-0045(19980615)36:1<31::aid-pros5>3.0.co;2-e. Prostate. 1998. PMID: 9650913 Clinical Trial.

10

Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer.

Li C, Berx G, Larsson C, Auer G, Aspenblad U, Pan Y, Sundelin B, Ekman P, Nordenskjöld M, van Roy F, Bergerheim US. Li C, et al. Among authors: bergerheim us. Genes Chromosomes Cancer. 1999 Mar;24(3):175-82. Genes Chromosomes Cancer. 1999. PMID: 10451696

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters